|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang L: Early diagnosis of breast cancer.
Sensors. 17(1572)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Korean Breast Cancer Society. Early
screening of breast cancer in Korea. J Korean Breast Cancer Soc.
5:225–234. 2002.
|
|
4
|
Devolli-Disha E, Manxhuka-Kërliu S, Ymeri
H and Kutllovci A: Comparative accuracy of mammography and
ultrasound in women with breast symptoms according to age and
breast density. Bosn J Basic Med Sci. 9:131–136. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Marrugo-Ramírez J, Mir M and Samitier J:
Blood-Based cancer biomarkers in liquid biopsy: A promising
non-invasive alternative to tissue biopsy. Int J Mol Sci.
19(2877)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bai Y and Zhao H: Liquid biopsy in tumors:
Opportunities and challenges. Ann Transl Med. 6(S89)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Castro-Giner F, Gkountela S, Donato C,
Alborelli I, Quagliata L, Ng CKY, Piscuoglio S and Aceto N: Cancer
diagnosis using a liquid biopsy: Challenges and expectations.
Diagnostics (Basel). 8(31)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Simpson RJ, Lim JW, Moritz RL and
Mathivanan S: Exosomes: Proteomic insights and diagnostic
potential. Expert Rev Proteomics. 6:267–283. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen X, Liang H, Zhang J, Zen K and Zhang
CY: Horizontal transfer of microRNAs: Molecular mechanisms and
clinical applications. Protein Cell. 3:28–37. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sanz-Rubio D, Martin-Burriel I, Gil A,
Cubero P, Forner M, Khalyfa A and Marin JM: Stability of
circulating Exosomal miRNAs in healthy subjects. Sci Rep.
8(10306)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Salehi M and Sharifi M: Exosomal miRNAs as
novel cancer biomarkers: Challenges and opportunities. J Cell
Physiol. 233:6370–6380. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A MicroRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801.
2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao H, Shen J, Medico L, Wang D,
Ambrosone CB and Liu S: A pilot study of circulating miRNAs as
potential biomarkers of early stage breast cancer. PLoS One.
5(e13735)2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Han J, Lee Y, Yeom KH, Kim YK, Jin H and
Kim VN: The Drosha-DGCR8 complex in primary microRNA processing.
Genes Dev. 18:3016–3027. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Suzuki HI and Miyazono K: Emerging
complexity of microRNA generation cascades. J Biochem. 149:15–25.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Salido-Guadarrama I, Romero-Cordoba S,
Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M:
MicroRNAs transported by exosomes in body fluids as mediators of
intercellular communication in cancer. Onco Targets Ther.
7:1327–1338. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lim SS and Kim YS:
WO2016137031-Dumbell-structure oligonucleotide, nucleic acid
amplification primer comprising same, and nucleic acid
amplification method using same. KR Patent WO/2016/137031. DIOGENE
Inc. Filed February 25, 2015; issued September 1, 2016.
|
|
27
|
Pinatel EM, Orso F, Penna E, Cimino D,
Elia AR, Circosta P, Dentelli P, Brizzi MF, Provero P and Taverna
D: miR-223 is a coordinator of breast cancer progression as
revealed by bioinformatics predictions. PLoS One.
9(e84859)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yoshikawa M, Iinuma H, Umemoto Y,
Yanagisawa T, Matsumoto A and Jinno H: Exosome-encapsulated
microRNA-223-3p as a minimally invasive biomarker for the early
detection of invasive breast cancer. Oncol Lett. 15:9584–9592.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fu L, Li Z, Zhu J, Wang P, Fan G, Dai Y,
Zheng Z and Liu Y: Serum expression levels of microRNA-382-3p,
-598-3p, -1246 and -184 in breast cancer patients. Oncol Lett.
12:269–274. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li XJ, Ren ZJ, Tang JH and Yu Q: Exosomal
MicroRNA miR-1246 Promotes Cell Proliferation, Invasion and Drug
Resistance by Targeting CCNG2 in Breast Cancer. Cell Physiol
Biochem. 44:1741–1748. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhou Y, Wang M, Tong Y, Liu X, Zhang L,
Dong D, Shao J and Zhou Y: miR-206 promotes cancer progression by
targeting Full-Length Neurokinin-1 Receptor in breast cancer.
Technol Cancer Res Treat. 18(1533033819875168)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Khodadadi-Jamayran A, Akgol-Oksuz B,
Afanasyeva Y, Heguy A, Thompson M, Ray K, Giro-Perafita A, Sánchez
I, Wu X, Tripathy D, et al: Prognostic role of elevated mir-24-3p
in breast cancer and its association with the metastatic process.
Oncotarget. 9:12868–12878. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lu K, Wang J, Song Y, Zhao S, Liu H, Tang
D, Pan B, Zhao H and Zhang Q: miRNA-24-3p promotes cell
proliferation and inhibits apoptosis in human breast cancer by
targeting p27Kip1. Oncol Rep. 34:995–1002.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Eichelser C, Flesch-Janys D, Chang-Claude
J, Pantel K and Schwarzenbach H: Deregulated Serum Concentrations
of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155 and
miR-373 in Human Breast Cancer Development and Progression. Clin
Chem. 59:1489–1496. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Piasecka D, Braun M, Kordek R, Sadej R and
Romanska H: MicroRNAs in regulation of triple-negative breast
cancer progression. J Cancer Res Clin Oncol. 144:1401–1411.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Asaga S, Kuo C, Nguyen T, Terpenning M,
Giuliano AE and Hoon DS: Direct serum assay for microRNA-21
concentrations in early and advanced breast cancer. Clin Chem.
57:84–91. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Corcoran C, Friel AM, Duffy MJ, Crown J
and O'Driscoll L: Intracellular and Extracellular MicroRNAs in
Breast Cancer. Clin Chem. 57:18–32. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shimomura A, Shiino S, Kawauchi J,
Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S,
Shimizu C, et al: Novel combination of serum microRNA for detecting
breast cancer in the early stage. Cancer Sci. 107:326–334.
2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7(e29770)2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhao C, Li X, Han B, You Z, Qu L, Liu C,
Song J, Lian L and Yang N: Gga-miR-219b targeting BCL11B suppresses
proliferation, migration and invasion of Marek's disease tumor cell
MSB1. Sci Rep. 7(4247)2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Løberg M, Lousdal ML, Bretthauer M and
Kalager M: Benefits and harms of mammography screening. Breast
Cancer Res. 17(63)2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Guo R, Lu G, Qin B and Fei B: Ultrasound
imaging technologies for breast cancer detection and management.
Ultrasound Med Biol. 44:37–70. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lebron-Zapata L and Jochelson MS: Overview
of breast cancer screening and diagnosis. PET Clin. 13:301–323.
2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Alimirzaie S, Bagherzadeh M and Akbari MR:
Liquid biopsy in breast cancer: A comprehensive review. Clin Genet.
95:643–660. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hamam R, Hamam D, Alsaleh KA, Kassem M,
Zaher W, Alfayez M, Aldahmash A and Alajez NM: Circulating
microRNAs in breast cancer: Novel diagnostic and prognostic
biomarkers. Cell Death Dis. 8(e3045)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
He Y, Deng F, Yang S, Wang D, Chen X,
Zhong S, Zhao J and Tang J: Exosomal microRNA: A novel biomarker
for breast cancer. Biomark Med. 12:177–188. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hannafon BN, Trigoso YD, Calloway CL, Zhao
YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC and Ding WQ:
Plasma exosome microRNAs are indicative of breast cancer. Breast
Cancer Res. 18(90)2016.PubMed/NCBI View Article : Google Scholar
|
